Drug Shortage Report for BREO ELLIPTA

Last updated on 2021-03-05 History
Report ID 134785
Drug Identification Number 02408872
Brand name BREO ELLIPTA
Common or Proper name fluticasone furoate/vilanterol (as trifenatate) dry powder for oral inhalation
Company Name GLAXOSMITHKLINE INC
Market Status MARKETED
Active Ingredient(s) VILANTEROL FLUTICASONE FUROATE
Strength(s) 25MCG 100MCG
Dosage form(s) POWDER
Route of administration INHALATION INHALATION
Packaging size 1x30
ATC code R03AK
ATC description ADRENERGICS, INHALANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-02-23
Estimated end date 2021-03-10
Actual end date 2021-03-04
Shortage status Resolved
Updated date 2021-03-05
Company comments
Health Canada comments
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2021-03-05 French Compare
v3 2021-03-05 English Compare
v2 2021-02-26 French Compare
v1 2021-02-26 English Compare